Veloxis Pharmaceuticals A/S Grants Warrants Under Existing

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
42
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program

Company Release no. 07/2019

To: NASDAQ Copenhagen A/S                                                

Copenhagen, Denmark, 04 April 2019

Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program

Today, the Board of Directors of Veloxis Pharmaceuticals A/S has decided to issue and grant warrants to current employees, the CFO and the Board of Directors of the Company under the existing Warrant Program covered by the authority under section 5E of the Company's Articles of Association. Thus, the Board of Directors of the Company has today partly exercised its authorization pursuant to the Articles of Association.

The purpose of the grant of warrants is to reflect the Company's objective to incentivize long-term shareholder value creation. The grant of warrants shall ensure to create - both in the short and in the long run - common interests between Board members and the employees and the shareholders of the Company.

A total of 33,705,338 warrants have been issued, giving the right to subscribe for up to 33,705,338 shares of nominally DKK 0.1 each. The exercise price is fixed at DKK 2.06.

The warrant holders earn the right to exercise the warrants with 1/36 per month as from the date of grant, 04 April 2019. Warrants which are not exercised on 04 April 2026 expire automatically.

The issued warrants are estimated to have a total market value of USD 4,260,259. The market value of the issued warrants is calculated on basis of the Black-Scholes model with a volatility calculated as 51.48%, an interest level of 0.22% and a share price of DKK 2.06.

For more information, please contact:

 Craig A. Collard      Ira Duarte
 President & CEO    CFO
 Phone: + 1 919 591 3090    Phone: +1 919 591 3090
 Email: cac@veloxis.com    Email: idu@veloxis.com

About Veloxis Pharmaceuticals

Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company committed to improving the lives of transplant patients.  A Danish company, Veloxis Pharmaceuticals A/S operates in the U.S. through Veloxis Pharmaceuticals Inc., a wholly-owned subsidiary headquartered in Cary, North Carolina, USA.  Veloxis has successfully developed Envarsus XR (tacrolimus extended-release tablets) based upon the company's unique and patented delivery technology, MeltDose®, which is designed to enhance the absorption and bioavailability of select orally administered drugs. The company is focused on the direct commercialization of Envarsus XR in the U.S., expansion of partnerships for markets around the world, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis is listed on the NASDAQ OMX Copenhagen under the trading symbol OMX: VELO.  For further information, please visit  www.veloxis.com .

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

RevSystems Joins Elite OpenAI Partner Network

Updated Category News Views 0

RevSystems Inks Deal with OpenAI Partner Network In the latest shuffle of the AI advisory deck, RevSystems just found itself elbowing into the exclusive OpenAI Partner Network. Based out of New York, RevSystems has carved a niche by spinning tech wizardry into tangible business results. Their new status as an OpenAI Select Partner puts them on a playing field where AI...

Continue Reading
AI Startup Shuttlebase Navigates Name Clash with Change

Updated Category News Views 6

When Two AI Giants Collide Every so often, we get a clash of titans in the business world, and this time it's in the AI universe. New York's Moonshot AI, a champ in autonomous website optimization, hit a bump when its name collided with a Chinese counterpart, also called Moonshot AI. And just like that, the NY company had to chuck their name out the window and don a new...

Continue Reading
The Austin Company to Showcase at ISPE Annual Event

Updated Category News Views 3

Setting the Stage at ISPE Expo When you think of pharmaceuticals and the bustle behind closed doors, it's with companies like The Austin Company leading the charge. This October, they're strutting their stuff at the ISPE Annual Meeting and Expo. No small potatoes here—it's at the Gaylord National in Maryland. Mark those dates: October 18-21, 2026. It's a circus of...

Continue Reading
Muscle Car Fever Revs Up in New Global TV Series

Updated Category News Views 2

Chasing the Dream on Wheels Amid the buzz of New York, there's a roar building up that's hard to ignore. It's a sound that echoes through time, capturing the imagination of petrol heads everywhere—those legendary American muscle cars are back in the limelight. I mean, who hasn't dreamt of launching down a highway in a '69 Ford Mustang? 'The Hunt for Rolling Treasure' is...

Continue Reading
CUBEX Lights Up Veterinary Care with Mini Essential

Updated Category News Views 2

Inventory Woes? Meet Mini Essential If you’ve ever worked in or around veterinary hospitals, you know the old-school headaches of managing controlled substances. Picture this: piles of paper logs, end-of-shift recounting, and inevitable discrepancies that rear their ugly heads long after closing time. Enter CUBEX, shaking things up with their latest launch, Mini...

Continue Reading
Alif Semiconductor Unveils StartKit for Edge AI MCU Fam

Updated Category News Views 3

Here's some clarity amidst the storm of buzzwords: Alif Semiconductor has rolled out something the market's been howling for—Edge AI that doesn't break the bank. It's less about slick press releases and more about real-world implications. We're talking accessibility with their dirt-cheap, small-form-factor StartKit platform for Ensemble and Balletto microcontrollers....

Continue Reading
ZEEKR's Shooting Brakes Dominate: Over 400K Sold

Updated Category News Views 2

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

Continue Reading
LeoLabs and SciTec Partner for $93.7M Space Force Deal

Updated Category News Views 1

LeoLabs and SciTec Join Forces for Space Dominance The space race ain't just about rockets blasting off anymore. It's about making sure we've got eyes everywhere, even on the back of our heads, so to speak. Enter LeoLabs teaming up with SciTec to help the U.S. Space Force upgrade their radar systems to something out of a sci-fi flick, armed with a $93.7 million contract...

Continue Reading
Wave Kids™ Unveils New Flavors for Kids' Drinks

Updated Category News Views 1

Sparking a Fresh Wave in the Kids' Beverage Market Alright, let me tell you about a new player plowing into the kids' drink scene. Wave Kids™, a brand that's making waves—pun intended—has a fresh lineup that screams 'fun' and 'healthy' in equal measure. Just coinciding with back-to-school season, this Scottsdale, Arizona outfit has rolled out not one or two, but...

Continue Reading
ABC Honors 2026 Spirit of the Heart Leaders

Updated Category News Views 3

Celebrating Champions of Cardiovascular Health In a world where accolades often feel as cold as the stock market after a crash, it’s heartening to see genuine recognition for those who are making actual, lasting impact. On October 3, 2026, the Association of Black Cardiologists (ABC) will hold its annual Spirit of the Heart Awards at none other than Cipriani Wall...

Continue Reading

Top 5 Most Recently Viewed Articles

Ashford Hospitality Trust Unveils Reverse Stock Split Strategy

Updated Category News Views 43

Ashford Hospitality Trust Announces Reverse Stock Split Ashford Hospitality Trust, Inc. (NYSE: AHT) has recently made a noteworthy announcement regarding a reverse stock split, approved unanimously by the Board of Directors. This strategic move involves a ratio of 1-for-10, which aims to bolster the company's stock value and ensure compliance with the New York Stock...

Continue Reading
Natural Grocers Explores Growth in Q3 Earnings Announcement

Updated Category News Views 94

Natural Grocers by Vitamin Cottage, Inc. Announces Earnings Call Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) is set to release its third quarter fiscal year 2025 financial results shortly after the market closes. Investors can expect this significant announcement to take place on a Thursday in early August. Following this release, the company will host a...

Continue Reading
Standard Motor Products Achieves Sustainability Recognition in 2026

Updated Category News Views 89

Standard Motor Products Celebrates Sustainability Recognition Standard Motor Products, Inc. (NYSE: SMP) is delighted to announce it has been recognized for the third consecutive year as one of America's Most Responsible Companies by Newsweek and Statista. This prestigious acknowledgment highlights the company’s commitment to sustainable and responsible practices within...

Continue Reading
Boeing Contributes $1 Million to Support Presidential Inauguration

Updated Category News Views 278

Boeing's Generous Donation for Presidential Inauguration Boeing, a leading aerospace company, has announced a significant contribution of $1 million to support the inauguration of the U.S. President-elect. This generous act demonstrates Boeing's commitment to participating in national events and supporting leadership transitions. Continuing a Tradition of Support This...

Continue Reading
RxSight, Inc. Faces Legal Scrutiny Amid Financial Declines

Updated Category News Views 107

Investigation Into RxSight, Inc. Pomerantz LLP is conducting an investigation into the claims regarding RxSight, Inc. (NASDAQ: RXST), focusing on whether the company and its executives have engaged in securities fraud or other unlawful business practices that could potentially harm investors. If you have invested in RxSight, it is important to stay informed and proactive....

Continue Reading